These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

520 related articles for article (PubMed ID: 35745063)

  • 21. Extracellular Vesicles - Advanced Nanocarriers in Cancer Therapy: Progress and Achievements.
    Huyan T; Li H; Peng H; Chen J; Yang R; Zhang W; Li Q
    Int J Nanomedicine; 2020; 15():6485-6502. PubMed ID: 32922012
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multifaceted role of extracellular vesicles in atherosclerosis.
    Konkoth A; Saraswat R; Dubrou C; Sabatier F; Leroyer AS; Lacroix R; Duchez AC; Dignat-George F
    Atherosclerosis; 2021 Feb; 319():121-131. PubMed ID: 33261815
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Exosomes and Other Extracellular Vesicles with High Therapeutic Potential: Their Applications in Oncology, Neurology, and Dermatology.
    Szwedowicz U; Łapińska Z; Gajewska-Naryniecka A; Choromańska A
    Molecules; 2022 Feb; 27(4):. PubMed ID: 35209095
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Approaches to incorporate extracellular vesicles into exposure science, toxicology, and public health research.
    Carberry CK; Keshava D; Payton A; Smith GJ; Rager JE
    J Expo Sci Environ Epidemiol; 2022 Sep; 32(5):647-659. PubMed ID: 35217808
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intercellular communication through extracellular vesicles in cancer and evolutionary biology.
    Bonner SE; Willms E
    Prog Biophys Mol Biol; 2021 Oct; 165():80-87. PubMed ID: 34391800
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Circulating Extracellular Vesicles As Biomarkers and Drug Delivery Vehicles in Cardiovascular Diseases.
    de Freitas RCC; Hirata RDC; Hirata MH; Aikawa E
    Biomolecules; 2021 Mar; 11(3):. PubMed ID: 33808038
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Extracellular Vesicles: An Emerging Clinical Opportunity in Musculoskeletal Disease.
    Rampam S; Carnino JM; Xiao B; Khan RR; Miyawaki S; Goh GS
    Tissue Eng Part B Rev; 2024 Jun; 30(3):359-370. PubMed ID: 37930727
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prospects and challenges of extracellular vesicle-based drug delivery system: considering cell source.
    Meng W; He C; Hao Y; Wang L; Li L; Zhu G
    Drug Deliv; 2020 Dec; 27(1):585-598. PubMed ID: 32264719
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Extracellular Vesicles in NAFLD/ALD: From Pathobiology to Therapy.
    Hernández A; Arab JP; Reyes D; Lapitz A; Moshage H; Bañales JM; Arrese M
    Cells; 2020 Mar; 9(4):. PubMed ID: 32231001
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Proteome and Citrullinome of
    Magnadóttir B; Kraev I; Dodds AW; Lange S
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33467210
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Extracellular Vesicles in Essential Hypertension: Hidden Messengers.
    La Salvia S; Gunasekaran PM; Byrd JB; Erdbrügger U
    Curr Hypertens Rep; 2020 Sep; 22(10):76. PubMed ID: 32880744
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Potential of Mesenchymal Stromal Cell-Derived Extracellular Vesicles as Natural Nanocarriers: Concise Review.
    Draguet F; Bouland C; Dubois N; Bron D; Meuleman N; Stamatopoulos B; Lagneaux L
    Pharmaceutics; 2023 Feb; 15(2):. PubMed ID: 36839879
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Extracellular Vesicle (EV) biohybrid systems for cancer therapy: Recent advances and future perspectives.
    Ou YH; Liang J; Czarny B; Wacker MG; Yu V; Wang JW; Pastorin G
    Semin Cancer Biol; 2021 Sep; 74():45-61. PubMed ID: 33609664
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of EV Storage Buffer for Efficient Preservation of Engineered Extracellular Vesicles.
    Kawai-Harada Y; El Itawi H; Komuro H; Harada M
    Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37629020
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Extracellular vesicles as carriers of mRNA: Opportunities and challenges in diagnosis and treatment.
    Kirian RD; Steinman D; Jewell CM; Zierden HC
    Theranostics; 2024; 14(5):2265-2289. PubMed ID: 38505610
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Extracellular Vesicles in Cardiovascular Theranostics.
    Bei Y; Das S; Rodosthenous RS; Holvoet P; Vanhaverbeke M; Monteiro MC; Monteiro VVS; Radosinska J; Bartekova M; Jansen F; Li Q; Rajasingh J; Xiao J
    Theranostics; 2017; 7(17):4168-4182. PubMed ID: 29158817
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Extracellular vesicles in respiratory disease.
    Carnino JM; Lee H
    Adv Clin Chem; 2022; 108():105-127. PubMed ID: 35659058
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Extracellular Vesicles in Facial Aesthetics: A Review.
    Kee LT; Ng CY; Al-Masawa ME; Foo JB; How CW; Ng MH; Law JX
    Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35743181
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Surface Glycan Profiling of Extracellular Vesicles by Lectin Microarray and Glycoengineering for Control of Cellular Interactions.
    Shimoda A; Akiyoshi K
    Pharm Res; 2023 Apr; 40(4):795-800. PubMed ID: 37038008
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Engineering Extracellular Vesicles with the Tools of Enzyme Prodrug Therapy.
    Fuhrmann G; Chandrawati R; Parmar PA; Keane TJ; Maynard SA; Bertazzo S; Stevens MM
    Adv Mater; 2018 Apr; 30(15):e1706616. PubMed ID: 29473230
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.